ADVITOS was founded in 2005 and developed the CE-marked and globally patented ADVOS technology. The company focuses on innovative multi-organ support systems designed to treat patients with liver, lung, and kidney failure. Its ADVOS (Advanced Organ Support) technology enables simultaneous detoxification of blood and support for multiple organs, offering a groundbreaking approach in intensive care medicine and improving outcomes for critically ill patients.